Home / Brands / Forest Pharmaceuticals
Forest Pharmaceuticals Recalls
6 recalls on record · February 12, 2014 to October 29, 2014 · Drugs
October 29, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Samp
Hazard: Failed Dissolution Specification; at the 6-month stability time point
July 9, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc.,
Hazard: Failed Dissolution Specifications: Drug failed stage III dissolution testing.
May 28, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license
Hazard: Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.
February 12, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, F
Hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
February 12, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-caps
Hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
February 12, 2014DrugsFDA
Forest Pharmaceuticals Inc recalls Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. L
Hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.